Skip to main content
Veterinary Medicines

OROSPRAY

Authorised
  • Chlortetracycline hydrochloride
  • Sulfanilamide

Product identification

Medicine name:
OROSPRAY
Active substance:
  • Chlortetracycline hydrochloride
  • Sulfanilamide
Target species:
  • Cattle
  • Pig
  • Cat
  • Equid
  • Sheep
  • Goat
  • Dog
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Chlortetracycline hydrochloride
    30.60
    milligram(s)
    /
    1.00
    gram(s)
  • Sulfanilamide
    500.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Cutaneous spray, solution
Withdrawal period by route of administration:
  • Cutaneous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        no withdrawal period
    • Pig
      • Meat and offal
        0
        day
    • Cat
    • Equid
      • Meat and offal
        0
        day
      • Milk
        no withdrawal period
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        no withdrawal period
    • Goat
      • Meat and offal
        0
        day
      • Milk
        no withdrawal period
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QD06AA52
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol S.A.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/2968555 6/1988
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
How useful was this page?:
Average: 5 (1 vote)
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."